Skip to content

Prevalence of fatty liver in a regional general affiliated hospital in Shanghai, China

Prevalence of fatty liver in a regional general affiliated hospital in Shanghai, China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096204
Enrollment
Unknown
Registered
2025-01-20
Start date
2024-06-05
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver/diabetes

Interventions

Observation Group:NA

Sponsors

Shanghai Jiao Tong University Renji Hospital Punan Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Outpatients or inpatients who underwent fibroscan examination at Shanghai Pudong Punan Hospital between 2023.07.20 and 2024.05.20 (Instrument model: Fibroscan HANDY) Fibroscan data should be complete and valid, and the instrument should be operated in accordance with the Fibroscan HANDY operation manual.

Exclusion criteria

Exclusion criteria: 1. patients aged 90 years; 2. No history of liver surgery such as liver transplantation or partial hepatectomy; 3. no serious systemic disease or any other condition that affects the patient's ability or compliance such as pregnancy, heart failure, clinically significant heart valve disease, serious mental illness and active malignant disease; 4. patients who are participating in clinical trials of other drugs that would cause fatty liver; 5. patients with diseases that would affect the accuracy of the fibroscan test, such as patients with severe decompensated cirrhosis.

Design outcomes

Primary

MeasureTime frame
Controlled attenuation parameter;Liver stiffness measurement;

Secondary

MeasureTime frame
Glycosylated Hemoglobin;Glutamic pyruvic transaminase;Glutamic oxaloacetic transaminase;Fasting C-Peptide;Fasting insulin;Triglycerid;Cholesterol;Low density lipoprotein;H density lipoprotein;total bilirubin;albumin;prealbumin;?-glutamyltranspeptidase;alkaline phosphatase;fasting blood-glucose;creatinine;eGFR;blood platelet;international normalized ratio;height;weight;body mass index;blood pressure;

Countries

China

Contacts

Public ContactWanjun Jiang

Shanghai Jiao Tong University Renji Hospital Punan Branch

jwjjy2021@163.com+86 135 6488 2796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026